English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAfter her stage 4 breast cancer diagnosis, independent filmmaker Kailee McGee decided not to leave her director’s chair. Instead, she leaned in and produced an award-winning short film about her experience.
Tag: triple-negative breast cancer
MD Anderson Research Highlights for September 4, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Lali Medina-Kauwe, PhD, Named Associate Dean of Cedars-Sinai PhD Programs
Lali Medina-Kauwe, PhD, a nationally regarded expert in molecular engineering and nanoparticle cancer research, has been named associate dean of PhD programs and director of the PhD program in Biomedical and Translational Sciences at Cedars-Sinai.
Study Uncovers Barriers to Mammography Screening Among Black Women
The study finds utilization of annual screening mammograms suboptimal among low-income Black women with several reported perceived and actual barriers. Most had a low breast cancer risk perception. Interestingly, participants perceived mammograms as very beneficial: 80 percent believed that ‘if breast cancer is found early, it’s likely that the cancer can be successfully treated;’ 90 percent indicated that ‘having a mammogram could help find breast cancer when it is first getting started.’
MEDIA ADVISORY: Cedars-Sinai Experts Available to Discuss New Mammogram Guidelines
Physician-scientists from Cedars-Sinai Cancer are available for interviews to discuss the new draft recommendation by the U.S. Preventive Services Task Force that women at average risk for breast cancer should have a mammogram every other year beginning at age 40.
MEDIA ADVISORY: Cedars-Sinai Experts Available During San Antonio Breast Cancer Symposium
Physician-scientists from Cedars-Sinai Cancer are available for comment on research being presented throughout the San Antonio Breast Cancer Symposium, taking place Dec. 6-10.
Physician Scientist to Lead Breast Oncology Program
Yuan Yuan, MD, PhD, a breast medical oncologist and physician scientist who specializes in triple-negative breast cancer and breast cancer immunotherapy, has joined Cedars-Sinai Cancer as director of Breast Oncology. Yuan will treat patients at Cedars-Sinai and at Huntington Cancer Center, an affiliate of Cedars-Sinai Cancer.
Cardamonin Shows Promise for Treating Aggressive Breast Cancer
Cardamonin — a natural compound found in the spice cardamom and other plants — could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show that the compound targets a gene that helps cancer cells elude the immune system.
Cleveland Clinic Launches First-of-its Kind Preventive Breast Cancer Vaccine Study
Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Statins may improve survival for triple-negative breast cancer patients
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an important impact on outcomes for this aggressive disease.
New sequencing approach finds triple-negative breast cancers continue accumulating genetic changes during tumor growth
A new DNA sequencing approach developed by MD Anderson researchers overcomes technical challenges with earlier techniques to give deeper insights into breast cancer evolution.
Multiethnic Tumor Models Aid in the Search for New Approaches Against Triple-Negative Breast Cancer
Breast cancer stem cells from patients with different racial and ethnic backgrounds showed important differences in activation of immune response-related genes in mouse models of triple-negative breast cancer.
HDAC6 Can Control Tumor Growth and Halt Metastasis in Triple-Negative Breast Cancer
Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the journal Cancer Research by investigators at the GW Cancer Center.